benserazide
PolandMedications containing this active substance
-
Madopar
Form: capsules
Active substance Dosage levodopa 200 mg benserazide 50 mg ATC: N04BA02
Manufacturer: Roche Pharma AG
-
Madopar 125 mg
Form: capsules
Active substance Dosage levodopa 100 mg benserazide 25 mg ATC: N04BA02
Manufacturer: Roche Pharma AG
-
Madopar 125 mg
Form: suspension, oral, for preparation from tablets
Active substance Dosage Levodopa 100 mg Benserazide 25 mg ATC: N04BA02
Manufacturer: Roche Pharma AG
-
Madopar 250 mg
Form: tablets
Active substance Dosage Levodopa 200 mg Benserazide 50 mg ATC: N04BA02
Manufacturer: ROCHE FARMA, S.A.
-
Madopar 250 mg
Form: tablets
Active substance Dosage Levodopa 200 mg Benserazide 50 mg ATC: N04BA02
Manufacturer: Roche s.r.o.
-
Madopar 250 mg
Form: tablets
Active substance Dosage levodopa 200 mg benserazide 50 mg ATC: N04BA02
Manufacturer: Roche Farma S.A.
-
Madopar 250 mg
Form: tablets
Active substance Dosage levodopa 200 mg benserazide 50 mg ATC: N04BA02
Manufacturer: Roche s.r.o.
-
Madopar 62.5 mg
Form: suspension, oral, for preparation from tablets
Active substance Dosage levodopa 50 mg benserazide 12.5 mg ATC: N04BA02
Manufacturer: Roche Pharma AG
-
Xevoben
Form: tablets
Active substance Dosage Levodopa 50 mg Benserazide 12.5 mg ATC: N04BA02
Manufacturer: Farmak International Sp. z o.o.
-
Xevoben
Form: tablets
Active substance Dosage Levodopa 100 mg Benserazide 25 mg ATC: N04BA02
Manufacturer: Farmak International Sp. z o.o.
-
Xevoben
Form: tablets
Active substance Dosage levodopa 200 mg benserazide 50 mg ATC: N04BA02
Manufacturer: Farmak International Sp. z o.o.
-
Xevoben xr
Form: capsules, extended release, hard
Active substance Dosage Levodopa 100 mg Benserazide 25 mg ATC: N04BA02
Manufacturer: Farmak International Sp. z o.o.